Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases

International Journal of Biological Markers

Volumn 21, Issue 4, 2006, Pages 223-228

  Trevisiol, Chiara ^a   Di Fabio, F ^b   Nascimbeni, R ^b   Peloso, L ^a   Salbe, C ^a   Ferruzzi, E ^a   Salerni, B ^b   Gion, M ^a  

^a Centre for the Study of Biological Markers of Malignancy   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Biological markers; Colorectal neoplasms; Genes; Prognosis; Ras; Serum

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; K RAS 2 PROTEIN; K RAS PROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; PREOPERATIVE EVALUATION; PROGNOSIS; SURGICAL TECHNIQUE;

EID: 33846537534     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.3336     Document Type: Article

References (33)

1. Alexander RJ, Buxbaum JN, Raicht RF. Oncogene alterations in primary human colon tumors. Gastroenterology 1986; 91: 1503-10.
2. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298-303.
3. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
4. Bodmer WF, Cottrell S, Frischauf AM, et al. Genetic analysis of colorectal cancer. Princess Takamatsu Symp 1989; 20: 49-59.
5. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. K-ras mutations in putative preneoplastic lesions in human colon. J. Natl Cancer Inst 1993; 85: 2004-7.
6. Korn SH, Moerkerk PT, de Goeij AF. K-ras point mutations in routinely processed tissues: non-radioactive screening by single strand conformational polymorphism analysis. J Clin Pathol 1993; 46: 621-3.
7. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer 1993; 71: 3827-38.
8. Chewawiwat N, Lulitanond V, Nimmanahaeminda K, Thamprasert K, Nicomrat D, Ponglikitmongkol M. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections. Southeast Asian J Trop Med Public Health 1995; 26 (Suppl 1): S329-32.
9. Losi L, Roncucci L, di Gregorio C, de Leon MP, Benhattar J. K-ras and p53 mutations in human colorectal aberrant crypt foci. J Pathol 1996; 178: 259-63.
10. Guan RJ, Fu Y, Holt PR, Pardee AB. Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology 1999; 116: 1063-71.
11. Servomaa K, Kiuru A, Kosma VM, Hirvikoski P, Rytomaa T. p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol 2000; 53: 24-30.
12. Andreyev HJ, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer 2001; 85: 692-6.
13. Garcia-Olmo DC, Ruiz-Piqueras R, Garcia-Olmo D. Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. Histol Histopathol 2004; 19: 575-83.
14. Anker P, Mulcahy H, Chen XQ Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999; 18: 65-73.
15. Johnson PJ, Lo YM. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002; 48: 1186-93.
16. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002; 28: 255-71.
17. Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003; 103: 149-52.
18. Wong BC, Lo YM. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev Mol Diagn 2003; 3: 785-97.
19. Anker P, Lefort F, Vasioukhin V, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997; 112: 1114-20.
20. de Kok JB, van Solinge WW, Ruers TJ, et al. Detection of tumour DNA in serum of colorectal cancer patients. Scand J Clin Lab Invest 1997; 57: 601-4.
21. Hibi K, Robinson CR, Booker S, et al. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998; 58: 1405-7.
22. Kopreski MS, Benko FA, Borys DJ, Khan A, McGarrity TJ, Gocke CD. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. J Natl Cancer Inst 2000; 92: 918-23.
23. Sorenson GD. A review of studies on the detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Ann NY Acad Sci 2000; 906: 13-6.
24. Lauschke H, Caspari R, Friedl W, et al. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer. Cancer Detect Prev 2001; 25: 55-61.
25. Borchers R, Heinzlmann M, Zahn R, et al. K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 715-8.
26. Ito S, Hibi K, Nakayama H, et al. Detection of tumor DNA in serum of colorectal cancer patients. Jpn J Cancer Res 2002; 93: 1266-9.
27. Salbe C, Trevisiol C, Ferruzzi E, et al. Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients. Int J Biol Markers 2000; 15: 300-7.
28. Ryan BM, Lefort F, McManus R, et al. A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up. Gut 2003; 52: 101-8.
29. Lecomte T, Berger A, Zinzindohoue F, et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 2002; 100: 542-8.
30. Kahlenberg MS, Sullivan JM, Witmer DD, Petrelli NJ. Molecular prognostics in colorectal cancer. Surg Oncol 2003; 12: 173-86.
31. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999; 79: 191-203.
32. Howe JR, Klimstra DS, Cordon-Cardo C. DNA extraction from paraffin-embedded tissues using a salting-out procedure: a reliable method for PCR amplification of archival material. Histol Histopathol 1997; 12: 595-601.
33. Minamoto T, Mai M, Ronai Z. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers - a review. Cancer Detect Prev 2000; 24: 1-12.